<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The State of Biotechnology, According to Biogen Idec CEO Jim Mullen</title>
	<atom:link href="http://www.xconomy.com/boston/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Paula Looker</title>
		<link>http://www.xconomy.com/boston/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/comment-page-1/#comment-5975</link>
		<dc:creator>Paula Looker</dc:creator>
		<pubDate>Fri, 04 Jan 2008 22:57:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/#comment-5975</guid>
		<description>Mr. Mullen
I have MS and take Avonex.  I am very troubled by the ever-increasing cost of this drug.  IT is now $1800 per month.  There will come a time when I cannot afford the product once I am off private insurance. I am 61 years old.  How do you defend the cost?  Biogen records huge profits and yet Avonex is so expensive to those who really can benefit from the therapy.</description>
		<content:encoded><![CDATA[<p>Mr. Mullen<br />
I have MS and take Avonex.  I am very troubled by the ever-increasing cost of this drug.  IT is now $1800 per month.  There will come a time when I cannot afford the product once I am off private insurance. I am 61 years old.  How do you defend the cost?  Biogen records huge profits and yet Avonex is so expensive to those who really can benefit from the therapy.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Doug Wilson</title>
		<link>http://www.xconomy.com/boston/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/comment-page-1/#comment-655</link>
		<dc:creator>Doug Wilson</dc:creator>
		<pubDate>Thu, 30 Aug 2007 14:36:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/#comment-655</guid>
		<description>I take great pride in telling people that I worked for Jim Mullen when he was 28.  It wasn&#039;t the easiest 2 years of my career, but it has propelled my career. Thanks, Jim.  I wish you every success.</description>
		<content:encoded><![CDATA[<p>I take great pride in telling people that I worked for Jim Mullen when he was 28.  It wasn’t the easiest 2 years of my career, but it has propelled my career. Thanks, Jim.  I wish you every success.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: VentureBeat &#187; Weekend update: The spinning of Baby Einstein, multiple-med confusion, and more</title>
		<link>http://www.xconomy.com/boston/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/comment-page-1/#comment-531</link>
		<dc:creator>VentureBeat &#187; Weekend update: The spinning of Baby Einstein, multiple-med confusion, and more</dc:creator>
		<pubDate>Mon, 20 Aug 2007 16:38:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2007/08/16/the-state-of-biotechnology-according-to-biogen-ceo-jim-mullen/#comment-531</guid>
		<description>[...] the future of biotech &#8212; In a lengthy interview with Robert Buderi of Xconomy.com (part one is here, part two is here), Biogen Idec CEO Jim Mullen waxes philosophical on what he sees as a coming era [...]</description>
		<content:encoded><![CDATA[<p>[...] the future of biotech — In a lengthy interview with Robert Buderi of Xconomy.com (part one is here, part two is here), Biogen Idec CEO Jim Mullen waxes philosophical on what he sees as a coming era [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

